Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alseres Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Jim Oravetz who wrote (943)	7/10/2002 1:38:49 PM
From: Jim Oravetz	Read Replies (1) \| Respond to of 975

Boston Life Sciences Names New President DOW JONES NEWSWIRES BOSTON -- Boston Life Sciences Inc. (BLSI) named Robert J. Rosenthal president succeeding David Hillson, 62 years old, who remains chairman and chief executive. Rosenthal, 45, was also named to the newly created position of chief operating officer. In a press release Wednesday, Boston Life said it needs greater management depth now that it is completing the transformation to a clinical product vehicle from a research, development and preclinical biotech entity. A company spokesman said Rosenthal had been president and chief executive of Magellan Discovery Technologies LLC of Boston. Company Web site: bostonlifesciencs.com